48 research outputs found
Levodopaâinduced dyskinesia are mediated by cortical gamma oscillations in experimental Parkinsonism
Background Levodopa is the most efficacious drug in the symptomatic therapy of motor symptoms in Parkinson's disease (PD); however, longâterm treatment is often complicated by troublesome levodopaâinduced dyskinesia (LID). Recent evidence suggests that LID might be related to increased cortical gamma oscillations. Objective The objective of this study was to test the hypothesis that cortical highâgamma network activity relates to LID in the 6âhydroxydopamine model and to identify new biomarkers for adaptive deep brain stimulation (DBS) therapy in PD. Methods We recorded and analyzed primary motor cortex (M1) electrocorticogram data and motor behavior in freely moving 6âOHDA lesioned rats before and during a daily treatment with levodopa for 3âweeks. The results were correlated with the abnormal involuntary movement score (AIMS) and used for generalized linear modeling (GLM). Results Levodopa reverted motor impairment, suppressed beta activity, and, with repeated administration, led to a progressive enhancement of LID. Concurrently, we observed a highly significant stepwise amplitude increase in finely tuned gamma (FTG) activity and gamma centroid frequency. Whereas AIMS and FTG reached their maximum after the 4th injection and remained on a stable plateau thereafter, the centroid frequency of the FTG power continued to increase thereafter. Among the analyzed gamma activity parameters, the fraction of longest gamma bursts showed the strongest correlation with AIMS. Using a GLM, it was possible to accurately predict AIMS from cortical recordings. Conclusions FTG activity is tightly linked to LID and should be studied as a biomarker for adaptive DBS
Atomic Transport in Dense, Multi-Component Metallic Liquids
Pd43Ni10Cu27P0 has been investigated in its equilibrium liquid state with
incoherent, inelastic neutron scattering. As compared to simple liquids, liquid
PdNiCuP is characterized by a dense packing with a packing fraction above 0.5.
The intermediate scattering function exhibits a fast relaxation process that
precedes structural relaxation. Structural relaxation obeys a time-temperature
superposition that extends over a temperature range of 540K. The mode-coupling
theory of the liquid to glass transition (MCT) gives a consistent description
of the dynamics which governs the mass transport in liquid PdNiCuP alloys. MCT
scaling laws extrapolate to a critical temperature Tc at about 20% below the
liquidus temperature. Diffusivities derived from the mean relaxation times
compare well with Co diffusivities from recent tracer diffusion measurements
and diffsuivities calculated from viscosity via the Stokes-Einstein relation.
In contrast to simple metallic liquids, the atomic transport in dense, liquid
PdNiCuP is characterized by a drastical slowing down of dynamics on cooling, a
q^{-2} dependence of the mean relaxation times at intermediate q and a
vanishing isotope effect as a result of a highly collective transport
mechanism. At temperatures as high as 2Tc diffusion in liquid PdNiCuP is as
fast as in simple liquids at the melting point. However, the difference in the
underlying atomic transport mechanism indicates that the diffusion mechanism in
liquids is not controlled by the value of the diffusivity but rather by that of
the packing fraction
Epidemiology of Coxiella burnetii infection in Africa: a OneHealth systematic review
Background:
Q fever is a common cause of febrile illness and community-acquired pneumonia in resource-limited settings. Coxiella burnetii, the causative pathogen, is transmitted among varied host species, but the epidemiology of the organism in Africa is poorly understood. We conducted a systematic review of C. burnetii epidemiology in Africa from a âOne Healthâ perspective to synthesize the published data and identify knowledge gaps.<p></p>
Methods/Principal Findings:
We searched nine databases to identify articles relevant to four key aspects of C. burnetii epidemiology in human and animal populations in Africa: infection prevalence; disease incidence; transmission risk factors; and infection control efforts. We identified 929 unique articles, 100 of which remained after full-text review. Of these, 41 articles describing 51 studies qualified for data extraction. Animal seroprevalence studies revealed infection by C. burnetii (≤13%) among cattle except for studies in Western and Middle Africa (18â55%). Small ruminant seroprevalence ranged from 11â33%. Human seroprevalence was <8% with the exception of studies among children and in Egypt (10â32%). Close contact with camels and rural residence were associated with increased seropositivity among humans. C. burnetii infection has been associated with livestock abortion. In human cohort studies, Q fever accounted for 2â9% of febrile illness hospitalizations and 1â3% of infective endocarditis cases. We found no studies of disease incidence estimates or disease control efforts.<p></p>
Conclusions/Significance:
C. burnetii infection is detected in humans and in a wide range of animal species across Africa, but seroprevalence varies widely by species and location. Risk factors underlying this variability are poorly understood as is the role of C. burnetii in livestock abortion. Q fever consistently accounts for a notable proportion of undifferentiated human febrile illness and infective endocarditis in cohort studies, but incidence estimates are lacking. C. burnetii presents a real yet underappreciated threat to human and animal health throughout Africa.<p></p>
Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational study
Purpose: Adequate patient allocation is pivotal for optimal resource management in strained healthcare systems, and requires detailed knowledge of clinical and virological disease trajectories. The purpose of this work was to identify risk factors associated with need for invasive mechanical ventilation (IMV), to analyse viral kinetics in patients with and without IMV and to provide a comprehensive description of clinical course.
Methods: A cohort of 168 hospitalised adult COVID-19 patients enrolled in a prospective observational study at a large European tertiary care centre was analysed.
Results: Forty-four per cent (71/161) of patients required invasive mechanical ventilation (IMV). Shorter duration of symptoms before admission (aOR 1.22 per day less, 95% CI 1.10-1.37, p < 0.01) and history of hypertension (aOR 5.55, 95% CI 2.00-16.82, p < 0.01) were associated with need for IMV. Patients on IMV had higher maximal concentrations, slower decline rates, and longer shedding of SARS-CoV-2 than non-IMV patients (33 days, IQR 26-46.75, vs 18 days, IQR 16-46.75, respectively, p < 0.01). Median duration of hospitalisation was 9 days (IQR 6-15.5) for non-IMV and 49.5 days (IQR 36.8-82.5) for IMV patients.
Conclusions: Our results indicate a short duration of symptoms before admission as a risk factor for severe disease that merits further investigation and different viral load kinetics in severely affected patients. Median duration of hospitalisation of IMV patients was longer than described for acute respiratory distress syndrome unrelated to COVID-19
Co-precipitation of MnO and Cu in an ionic liquid as a first step toward self-formed barrier layers
SSCI-VIDE+ATARI:ING+LMA:JROInternational audience--
Differential effects of levodopa and apomorphine on neuronal population oscillations in the cortico-basal ganglia loop circuit in vivo in experimental parkinsonism
The current pharmacotherapy of Parkinson's disease (PD) is primarily based on two classes of drugs: dopamine precursors, namely levodopa, and dopamine receptor agonists, such as apomorphine. Although both types of agents exert their beneficial clinical effects on motor and non-motor symptoms in PD via dopamine receptors, clinical efficiency and side effects differ substantially between levodopa and apomorphine. Levodopa can provide a greater symptomatic relief than dopamine receptor agonists. However, because long-term levodopa use is associated with early debilitating motor fluctuations, dopamine receptor agonists are often recommended in younger patients. The pharmacodynamic basis of these profound differences is incompletely understood. It has been hypothesized that levodopa and dopamine receptor agonists may have diverging effects on beta and gamma oscillations that have been shown to be of importance for the pathophysiology of PD. Here, we used electrophysiological recordings in anesthetized dopamine-intact and dopamine-depleted rats to systemically compare the impact of levodopa or apomorphine on neuronal population oscillations in three nodes of the cortico-basal ganglia loop circuit. Our results showed that levodopa had a higher potency than apomorphine to suppress the abnormal beta oscillations often associated with bradykinesia while simultaneously enhancing the gamma oscillations often associated with increased movement. Our data suggests that the higher clinical efficacy of levodopa as well as some of its side effects, as e.g. dyskinesias may be based on its characteristic ability to modulate beta-/gamma-oscillation dynamics in the cortico-basal ganglia loop circuit
Reply to: "Levodopaâinduced dyskinesia are mediated by cortical gamma oscillations in experimental Parkinsonism"
Background Levodopa is the most efficacious drug in the symptomatic therapy of motor symptoms in Parkinson's disease (PD); however, longâterm treatment is often complicated by troublesome levodopaâinduced dyskinesia (LID). Recent evidence suggests that LID might be related to increased cortical gamma oscillations. Objective The objective of this study was to test the hypothesis that cortical highâgamma network activity relates to LID in the 6âhydroxydopamine model and to identify new biomarkers for adaptive deep brain stimulation (DBS) therapy in PD. Methods We recorded and analyzed primary motor cortex (M1) electrocorticogram data and motor behavior in freely moving 6âOHDA lesioned rats before and during a daily treatment with levodopa for 3âweeks. The results were correlated with the abnormal involuntary movement score (AIMS) and used for generalized linear modeling (GLM). Results Levodopa reverted motor impairment, suppressed beta activity, and, with repeated administration, led to a progressive enhancement of LID. Concurrently, we observed a highly significant stepwise amplitude increase in finely tuned gamma (FTG) activity and gamma centroid frequency. Whereas AIMS and FTG reached their maximum after the 4th injection and remained on a stable plateau thereafter, the centroid frequency of the FTG power continued to increase thereafter. Among the analyzed gamma activity parameters, the fraction of longest gamma bursts showed the strongest correlation with AIMS. Using a GLM, it was possible to accurately predict AIMS from cortical recordings. Conclusions FTG activity is tightly linked to LID and should be studied as a biomarker for adaptive DBS
Bimetallic Ru-Cu Nanoparticles Synthesized in Ionic Liquids: Kinetically Controlled Size and Structure
MATERIAUX:SURFACES+MAO:LMA:JROWe report a new synthesis of size-controlled bimetallic Ru-Cu nanoparticles (NPs) in ionic liquids using two organometallic precursors. Interestingly enough, upon mixing ruthenium and copper precursors, smaller bimetallic NPs (1.9-2.8 nm) are formed as compared to single metals (Cu: 5 nm; Ru: 4 nm) in a large range of copper molar fractions (chi(Cu) = 0.005-0.91). Surface and microscopy techniques evidence that NPs have metallic copper on the surface and crystalline hexagonal close-packed metallic ruthenium core. This structure is further assessed by the catalytic activity of the bimetallic NPs, showing that conversion of benzene in cyclohexane is reduced with increasing chi(Cu)